statistiche ricercatore

Continente	#
NA - Nord America	1.155
EU - Europa	996
AS - Asia	662
SA - Sud America	114
AF - Africa	31
Continente sconosciuto - Info sul continente non disponibili	26
OC - Oceania	5
Totale	2.989

Nazione	#
US - Stati Uniti d'America	1.120
DE - Germania	387
SG - Singapore	240
CN - Cina	227
SE - Svezia	165
PL - Polonia	108
BR - Brasile	96
IT - Italia	88
UA - Ucraina	60
FR - Francia	53
VN - Vietnam	37
GB - Regno Unito	34
IN - India	29
IE - Irlanda	26
HK - Hong Kong	22
ID - Indonesia	19
JP - Giappone	19
FI - Finlandia	17
RU - Federazione Russa	17
CA - Canada	16
BD - Bangladesh	11
IQ - Iraq	10
MX - Messico	10
ZA - Sudafrica	9
KR - Corea	8
NL - Olanda	8
CI - Costa d'Avorio	7
CO - Colombia	7
GR - Grecia	6
TR - Turchia	6
AU - Australia	5
ES - Italia	5
IR - Iran	5
PK - Pakistan	5
CZ - Repubblica Ceca	4
LT - Lituania	4
UZ - Uzbekistan	4
AR - Argentina	3
BG - Bulgaria	3
JO - Giordania	3
SA - Arabia Saudita	3
TN - Tunisia	3
VE - Venezuela	3
AE - Emirati Arabi Uniti	2
AT - Austria	2
CR - Costa Rica	2
EC - Ecuador	2
EG - Egitto	2
HN - Honduras	2
HU - Ungheria	2
JM - Giamaica	2
KE - Kenya	2
MA - Marocco	2
MY - Malesia	2
PH - Filippine	2
TH - Thailandia	2
TT - Trinidad e Tobago	2
XK - ???statistics.table.value.countryCode.XK???	2
A1 - Anonimo	1
AL - Albania	1
AO - Angola	1
AW - Aruba	1
AZ - Azerbaigian	1
BE - Belgio	1
BO - Bolivia	1
BW - Botswana	1
CL - Cile	1
DZ - Algeria	1
GH - Ghana	1
HR - Croazia	1
KG - Kirghizistan	1
KZ - Kazakistan	1
LK - Sri Lanka	1
LV - Lettonia	1
MZ - Mozambico	1
NO - Norvegia	1
NP - Nepal	1
OM - Oman	1
PY - Paraguay	1
RO - Romania	1
SI - Slovenia	1
SN - Senegal	1
Totale	2.966

Nome	#
Fanconi anemia gene variants in therapy-related myeloid neoplasms	331
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies	272
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome.	247
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES	245
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES	244
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA	221
Why methylation is not a marker predictive of response to hypomethylating agents	204
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms	194
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes	194
SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms.	188
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases	178
Clonal evolution in therapy-related neoplasms	178
The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes	154
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes	139
Totale	2.989

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	162	0	16	1	5	11	11	3	43	10	20	21	21
2022/2023	392	65	61	26	77	17	35	15	40	29	0	20	7
2023/2024	170	10	37	5	10	4	51	1	10	5	2	19	16
2024/2025	255	6	5	30	7	41	4	23	9	26	21	51	32
2025/2026	735	96	13	35	63	122	50	139	32	104	53	18	10
2026/2027	51	31	20	0	0	0	0	0	0	0	0	0	0
Totale													2.989

IRIS UniCatt